242 related articles for article (PubMed ID: 26783288)
1. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma.
Ekmekcioglu S; Davies MA; Tanese K; Roszik J; Shin-Sim M; Bassett RL; Milton DR; Woodman SE; Prieto VG; Gershenwald JE; Morton DL; Hoon DS; Grimm EA
Clin Cancer Res; 2016 Jun; 22(12):3016-24. PubMed ID: 26783288
[TBL] [Abstract][Full Text] [Related]
2. CD74: a new prognostic factor for patients with malignant pleural mesothelioma.
Otterstrom C; Soltermann A; Opitz I; Felley-Bosco E; Weder W; Stahel RA; Triponez F; Robert JH; Serre-Beinier V
Br J Cancer; 2014 Apr; 110(8):2040-6. PubMed ID: 24594996
[TBL] [Abstract][Full Text] [Related]
3. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma.
Johansson CC; Egyházi S; Masucci G; Harlin H; Mougiakakos D; Poschke I; Nilsson B; Garberg L; Tuominen R; Linden D; Stolt MF; Hansson J; Kiessling R
Cancer Immunol Immunother; 2009 Jul; 58(7):1085-94. PubMed ID: 19039588
[TBL] [Abstract][Full Text] [Related]
5. Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
Verjans E; Noetzel E; Bektas N; Schütz AK; Lue H; Lennartz B; Hartmann A; Dahl E; Bernhagen J
BMC Cancer; 2009 Jul; 9():230. PubMed ID: 19602265
[TBL] [Abstract][Full Text] [Related]
6. Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690.
Kashani-Sabet M; Nosrati M; Miller JR; Sagebiel RW; Leong SPL; Lesniak A; Tong S; Lee SJ; Kirkwood JM
Clin Cancer Res; 2017 Nov; 23(22):6888-6892. PubMed ID: 28790109
[No Abstract] [Full Text] [Related]
7. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
[TBL] [Abstract][Full Text] [Related]
8. The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival.
Ogata D; Roszik J; Oba J; Kim SH; Bassett RL; Haydu LE; Tanese K; Grimm EA; Ekmekcioglu S
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33327409
[TBL] [Abstract][Full Text] [Related]
9. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
10. Tumor iNOS predicts poor survival for stage III melanoma patients.
Ekmekcioglu S; Ellerhorst JA; Prieto VG; Johnson MM; Broemeling LD; Grimm EA
Int J Cancer; 2006 Aug; 119(4):861-6. PubMed ID: 16557582
[TBL] [Abstract][Full Text] [Related]
11. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.
Cheng RJ; Deng WG; Niu CB; Li YY; Fu Y
Int J Gynecol Cancer; 2011 Aug; 21(6):1004-12. PubMed ID: 21792010
[TBL] [Abstract][Full Text] [Related]
12. Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.
Xiong C; Huang B; Cun Y; Aghdasi BG; Zhou Y
Clin Orthop Relat Res; 2014 Jun; 472(6):1943-54. PubMed ID: 24569872
[TBL] [Abstract][Full Text] [Related]
13. [Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia].
Xie XF; Zhan Y; Ye YH; Li C; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):278-82. PubMed ID: 20646540
[TBL] [Abstract][Full Text] [Related]
14. CD74 expression and its therapeutic potential in thyroid carcinoma.
Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
Imaoka M; Tanese K; Masugi Y; Hayashi M; Sakamoto M
Cancer Sci; 2019 Jul; 110(7):2273-2283. PubMed ID: 31069878
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
[TBL] [Abstract][Full Text] [Related]
17. Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas.
Cuthbert RJ; Wilson JM; Scott N; Coletta PL; Hull MA
Eur J Cancer; 2009 Jun; 45(9):1654-63. PubMed ID: 19269807
[TBL] [Abstract][Full Text] [Related]
18. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
Xia W; Zhang F; Xie C; Jiang M; Hou M
Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
[TBL] [Abstract][Full Text] [Related]
20. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]